Sunir Garg, MD, recalls his first patient with exudative (wet) macular degeneration during residency and the limited therapeutic options that were available to treat this condition at that time, as well as the uncomfortable conversations that he had with patients.
Dr Garg tracks the evolution of therapeutic options in wet AMD from the period in the early 2000s when the only option was laser photocoagulation, to the introduction of anti-VEGF therapy. These current options can not only halt disease progression but also have the potential to restore some vision loss.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Tracking the Evolution of Management Options in Wet AMD - Medscape - May 09, 2022.